Dr. Srijana Rai MD?
Update this Profile
Dr. Srijana Rai MD, Hematologist-Oncologist
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Srijana Rai MD

Hematologist-Oncologist | Hematology & Oncology

803 S MAIN ST STE 210 MOSCOW ID, 83843

About

Dr. Srijana Rai is a hematologist oncologist practicing in MOSCOW, ID. Dr. Rai specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Provider Details

FemaleEnglish

Dr. Srijana Rai MD's Practice location

803 S MAIN ST STE 210 -
MOSCOW, ID 83843
Get Direction
New patients: 509-228-1000
Fax: 509-252-9300

Dr. Srijana Rai MD's reviews

(0)
Write Review

Recommended Articles

  • 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial

    When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...

  • The Effect of Sunshine on Lymphoma

    Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

  • Treatment Update for Hodgkin Lymphoma

    Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

  • Morphos Declared a "Breakthrough Therapy" for Lymphoma

    MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...

  • Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux

    Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...

  • The Promising Future of Gene Therapy and Lymphoma

    Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...